Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February–6 June 2020. (2020)

• Record Type: Journal Article
• Authors: Elimian, K. O.; Ochu, C. L.; Ilori, E.; Oladejo, J.; Igumbor, E.; Steinhardt, L.; Wagai, J.; Arinze, C.; Ukponu, W.; Obiekea, C.; Aderinola, O.; Crawford, E.; Olayinka, A.; Dan-Nwafor, C.; Okwor, T.; Disu, Y.; Yinka-Ogunleye, A.; Kanu, N. E.; Olawepo, O. A.; Aruna, O.; Michael, C. A.; Dunkwu, L.; Ipadeola, O.; Naidoo, D.; Umeokonkwo, C. D.; Matthias, A.; Okunromade, O.; Badaru, S.; Jinadu, A.; Ogunbode, O.; Egwuenu, A.; Jafiya, A.; Dalhat, M.; Saleh, F.; Ebhodaghe, G. B.; Ahumibe, A.; Yashe, R. U.; Atteh, R.; Nwachukwu, W. E.; Ezeokafor, C.; Olaleye, D.; Habib, Z.; Abdus-Salam, I.; Pembi, E.; John, D.; Okhuarobo, U. J.; Assad, H.; Gandi, Y.; Muhammad, B.; Nwagwogu, C.; Nwadiuto, I.; Sulaiman, K.; Iwuji, I.; Okeji, A.; Thliza, S.; Fagbemi, S.; Usman, R.; Mohammed, A. A.; Adeola-Musa, O.; Ishaka, M.; Aketemo, U.; Kamaldeen, K.; Obagha, C. E.; Akinyode, A. O.; Nguku, P.; Mba, N.; Ihekweazu, C.;
• Is Part Of: Epidemiology and infection. Volume 148(2020)
• Publication Date: 2020
• Subjects: Asymptomatic, -- case fatality, -- COVID-19, -- cumulative incidence, -- epidemiology, -- Nigeria; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S095026882000206X
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: The objective of this study was to describe the epidemiology of COVID-19 in Nigeria with a view of generating evidence to enhance planning and response strategies. A national surveillance dataset between 27 February and 6 June 2020 was retrospectively analysed, with confirmatory testing for COVID-19 done by real-time polymerase chain reaction (RT-PCR). The primary outcomes were cumulative incidence (CI) and case fatality (CF). A total of 40 926 persons (67% of total 60 839) had complete records of RT-PCR test across 35 states and the Federal Capital Territory, 12 289 (30.0%) of whom were confirmed COVID-19 cases. Of those confirmed cases, 3467 (28.2%) had complete records of clinical outcome (alive or dead), 342 (9.9%) of which died. The overall CI and CF were 5.6 per 100 000 population and 2.8%, respectively. The highest proportion of COVID-19 cases and deaths were recorded in persons aged 31–40 years (25.5%) and 61–70 years (26.6%), respectively; and males accounted for a higher proportion of confirmed cases (65.8%) and deaths (79.0%). Sixty-six per cent of confirmed COVID-19 cases were asymptomatic at diagnosis. In conclusion, this paper has provided an insight into the early epidemiology of COVID-19 in Nigeria, which could be useful for contextualising public health planning.